<code id='BF69E43AEF'></code><style id='BF69E43AEF'></style>
    • <acronym id='BF69E43AEF'></acronym>
      <center id='BF69E43AEF'><center id='BF69E43AEF'><tfoot id='BF69E43AEF'></tfoot></center><abbr id='BF69E43AEF'><dir id='BF69E43AEF'><tfoot id='BF69E43AEF'></tfoot><noframes id='BF69E43AEF'>

    • <optgroup id='BF69E43AEF'><strike id='BF69E43AEF'><sup id='BF69E43AEF'></sup></strike><code id='BF69E43AEF'></code></optgroup>
        1. <b id='BF69E43AEF'><label id='BF69E43AEF'><select id='BF69E43AEF'><dt id='BF69E43AEF'><span id='BF69E43AEF'></span></dt></select></label></b><u id='BF69E43AEF'></u>
          <i id='BF69E43AEF'><strike id='BF69E43AEF'><tt id='BF69E43AEF'><pre id='BF69E43AEF'></pre></tt></strike></i>

          focus

          focus

          author:comprehensive    Page View:8
          Two business miniatures talk to each other on coin stacks that are sandwiched by a syringe and a stethoscope — coverage from STAT
          Adobe

          For all the flak they get, the country’s four biggest pharmacy benefit managers reported a surprisingly tame average profit margin in the first three quarters of 2023: 4.5%, less than a third of their drugmaker peers.

          But don’t take their numbers as gospel, experts warned.

          advertisement

          “It’s really easy to move money around inside the books of a vertically integrated organization,” said Karen Van Nuys, a senior fellow at the USC Schaeffer Center for Health Policy and Economics. “If one segment of your vertically integrated organization is not publishing any financial data, it’s a good place to hide stuff.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more
          Virtual Event: March of the Biosimilars
          Virtual Event: March of the Biosimilars

          Editor’snote:Arecordingoftheeventisembeddedbelow.SeveralbiosimilarversionsofHumira,whichforyearshasb

          read more
          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more

          CVS is willing to dump 10% of its Medicare Advantage members

          AdobeCVSHealthispreparingtomakesignificantchangestoits2025MedicareAdvantageplans,whichcouldpotential